Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis

Clicks: 216
ID: 269328
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
As a treatment for alcohol use disorders, baclofen is associated with higher rates of abstinence than placebo. However, there is no superior effect of baclofen on increasing number of abstinent days, or decreasing heavy drinking, craving, anxiety or depression. These results suggest that the current …
Reference Key
ak2018addictionbaclofen: Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rose AK;Jones A;;
Journal addiction (abingdon, england)
Year 2018
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29479827&dopt=Abstract
Keywords
meta-analysis National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine randomized controlled trials as topic anxiety / psychology depression / psychology affect alcoholism / psychology baclofen / therapeutic use* pmid:29479827 doi:10.1111/add.14191 abigail k rose andrew jones alcohol abstinence alcohol drinking alcoholism / drug therapy* craving* gaba-b receptor agonists / therapeutic use*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.